1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Blood Bank Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Blood Bank Market, by Product
8.1.1. Blood Components
8.1.1.1. Market Revenue and Forecast
8.1.2. Equipment(Blood Banking Devices)
8.1.2.1. Market Revenue and Forecast
8.1.3. Consumables & Reagents
8.1.3.1. Market Revenue and Forecast
8.1.4. Software & Services
8.1.4.1. Market Revenue and Forecast
9.1. Blood Bank Market, by Function
9.1.1. Collection
9.1.1.1. Market Revenue and Forecast
9.1.2. Processing (Separation)
9.1.2.1. Market Revenue and Forecast
9.1.3. Testing (Screening and Typing)
9.1.3.1. Market Revenue and Forecast
9.1.4. Storage
9.1.4.1. Market Revenue and Forecast
9.1.5. Transportation
9.1.5.1. Market Revenue and Forecast
9.1.6. Transfusion
9.1.6.1. Market Revenue and Forecast
10.1. Blood Bank Market, by Bank Type
10.1.1. Public Blood Banks
10.1.1.1. Market Revenue and Forecast
10.1.2. Private Blood Banks
10.1.2.1. Market Revenue and Forecast
11.1. Blood Bank Market, by End User
11.1.1. Hospitals (In-house Blood Banks and Transfusion Services)
11.1.1.1. Market Revenue and Forecast
11.1.2. Ambulatory Surgical Centers (ASCs) & Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Diagnostic & Pathology Laboratories
11.1.3.1. Market Revenue and Forecast
11.1.4. Standalone Blood Centers/Blood Banks (Independent)
11.1.4.1. Market Revenue and Forecast
11.1.5. Research & Academic Institutes
11.1.5.1. Market Revenue and Forecast
11.1.5. Research & Academic Institutes
11.1.5.1. Pharmaceutical & Biotechnology Companies
12.1. North America
12.1.1. Market Revenue and Forecast, by Product
12.1.2. Market Revenue and Forecast, by Function
12.1.3. Market Revenue and Forecast, by Bank Type
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product
12.1.5.2. Market Revenue and Forecast, by Function
12.1.5.3. Market Revenue and Forecast, by Bank Type
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product
12.1.6.2. Market Revenue and Forecast, by Function
12.1.6.3. Market Revenue and Forecast, by Bank Type
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product
12.2.2. Market Revenue and Forecast, by Function
12.2.3. Market Revenue and Forecast, by Bank Type
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product
12.2.5.2. Market Revenue and Forecast, by Function
12.2.5.3. Market Revenue and Forecast, by Bank Type
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product
12.2.6.2. Market Revenue and Forecast, by Function
12.2.6.3. Market Revenue and Forecast, by Bank Type
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product
12.2.7.2. Market Revenue and Forecast, by Function
12.2.7.3. Market Revenue and Forecast, by Bank Type
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product
12.2.8.2. Market Revenue and Forecast, by Function
12.2.8.3. Market Revenue and Forecast, by Bank Type
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product
12.3.2. Market Revenue and Forecast, by Function
12.3.3. Market Revenue and Forecast, by Bank Type
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product
12.3.5.2. Market Revenue and Forecast, by Function
12.3.5.3. Market Revenue and Forecast, by Bank Type
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product
12.3.6.2. Market Revenue and Forecast, by Function
12.3.6.3. Market Revenue and Forecast, by Bank Type
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product
12.3.7.2. Market Revenue and Forecast, by Function
12.3.7.3. Market Revenue and Forecast, by Bank Type
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product
12.3.8.2. Market Revenue and Forecast, by Function
12.3.8.3. Market Revenue and Forecast, by Bank Type
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product
12.4.2. Market Revenue and Forecast, by Function
12.4.3. Market Revenue and Forecast, by Bank Type
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product
12.4.5.2. Market Revenue and Forecast, by Function
12.4.5.3. Market Revenue and Forecast, by Bank Type
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product
12.4.6.2. Market Revenue and Forecast, by Function
12.4.6.3. Market Revenue and Forecast, by Bank Type
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product
12.4.7.2. Market Revenue and Forecast, by Function
12.4.7.3. Market Revenue and Forecast, by Bank Type
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product
12.4.8.2. Market Revenue and Forecast, by Function
12.4.8.3. Market Revenue and Forecast, by Bank Type
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product
12.5.2. Market Revenue and Forecast, by Function
12.5.3. Market Revenue and Forecast, by Bank Type
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product
12.5.5.2. Market Revenue and Forecast, by Function
12.5.5.3. Market Revenue and Forecast, by Bank Type
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product
12.5.6.2. Market Revenue and Forecast, by Function
12.5.6.3. Market Revenue and Forecast, by Bank Type
12.5.6.4. Market Revenue and Forecast, by End User
13.1. America's Blood Centers
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Australian Red Cross Society
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Blood Bank of Alaska
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Canadian Blood Services
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Japanese Red Cross Society
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. New York Blood Center
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sanquin Blood Supply Foundation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. The American Red Cross
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vitalant
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. NHS Blood and Transplant
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
